Research Article
Evaluation of the Pharmacokinetics and Hepatoprotective Effects of Phillygenin in Mouse
Table 2
Pharmacokinetic parameters of phillygenin after single oral (24 mg/kg) or iv (12 mg/kg) to mice.
| Parameter | po (24 mg/kg) | iv (12 mg/kg) |
| (μg·min/mL) | 71.3 | 63.2 | (μg·min/mL) | 72.5 | 76.2 | Vd (mL/kg) | c NC | 300 | CL (mL/min/kg) | 345 | 156 | (g/mL) | bNQ | 3.14 | (g/mL) | 0.7 | - - | (min) | 30 | - - | (min) | c NC | 3.78 | (min) | cNC | 630 | A Half-life (min) | 54.8 | - - | D Half–life (min) | 150 | a NC | E Half-life (min) | 240 | aNC | F () | 56.4 | - - |
|
|
aNC = not calculated; low levels did not allow calculation of terminal half-life and . |